Healthcare
Aditxt Inc. Subsidiary Pearsanta Engages Spartan Capital for Planned IPO to Advance Cancer Detection
Aditxt Inc.'s subsidiary Pearsanta, Inc. has taken a significant step towards its Initial Public Offering by appointing Spartan Capital Securities, LLC as the lead underwriter, aiming to enhance early cancer and disease detection technologies.
Calidi Biotherapeutics Inc. Receives FDA Fast Track Designation for CLD-201 in Soft Tissue Sarcoma
Calidi Biotherapeutics Inc. has been granted FDA Fast Track designation for its CLD-201 treatment, marking a significant step forward in the development of therapies for soft tissue sarcoma and other cancers.
NanoCell Therapeutics' NCtx Platform Could Revolutionize CAR-T Therapy Accessibility
NanoCell Therapeutics' research demonstrates a novel method for in vivo CAR-T cell generation, potentially reducing costs and increasing access to life-saving cancer treatments.
American Heart Association Recognizes Nearly 5,000 Organizations for Excellence in Cardiovascular Care
The American Heart Association has recognized 4,859 organizations for their commitment to improving cardiovascular care, highlighting the importance of evidence-based treatments in reducing deaths from heart disease and stroke.
158 Hospitals Nationwide Honored for Excellence in Cardiovascular Care
The American Heart Association recognizes 158 hospitals with the Commitment to Quality award for their high performance in comprehensive cardiovascular care, underscoring the importance of evidence-based treatments in combating heart disease and stroke.
Fifty 1 Labs, Inc. (OTC: FITY) Showcases AI-Driven Growth Strategy in Virtual Shareholder Teleconference
Fifty 1 Labs, Inc. (OTC: FITY) highlighted its AI-driven strategy for the functional medicine and biotech sectors during a virtual teleconference, emphasizing significant market opportunities and shareholder value creation.
Study Reveals Autoantibodies' Role in Enhancing Cancer Immunotherapy Efficacy
A recent study highlights the potential of autoantibodies in predicting the effectiveness of cancer immunotherapy, offering a new avenue for personalized treatment strategies.
Scinai Immunotherapeutics Ltd. Announces Peer-Reviewed Data Supporting PC111 as Potential Disease Modifier
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) has published peer-reviewed data in the Journal of Dermatological Treatment, highlighting PC111's potential as a disease modifier for pemphigus and SJS/TEN, offering a new, non-immunosuppressive treatment approach.
Izotropic Corporation's IzoView Breast CT Imaging System Offers Advanced Breast Cancer Detection
Izotropic Corporation introduces the IzoView Breast CT Imaging System, a breakthrough in breast cancer detection offering superior 3D imaging without compression, aiming to enhance diagnosis and treatment planning.
GeoVax Accelerates GEO-MVA Vaccine Development Amid Global Mpox Crisis
GeoVax Labs, Inc. is expediting the development of its GEO-MVA Mpox vaccine in response to a global surge in cases and the WHO's reaffirmation of Mpox as a public health emergency, highlighting the urgent need for scalable and equitable vaccine solutions.
Healing House's Martini Tour and Gala Supports Grieving Families in Acadiana
The annual Martini Tour and Gala by Healing House brings together the Lafayette community to support children and families grieving the loss of a loved one through innovative fundraising and awareness.
hyperCORE International Appoints Nicholas Focil as New President
Nicholas Focil's appointment as president of hyperCORE International signals a strategic move to enhance the network's global clinical research impact through his extensive experience in clinical operations and diversity in trials.
Creative Biolabs Advances Single-Domain Antibody Solutions to Meet Therapeutic Demands
Creative Biolabs is enhancing the development of single-domain antibodies (sdAbs), offering innovative solutions for oncology, neurology, and infectious diseases, highlighting their potential to revolutionize treatment approaches.
Creative Biolabs to Showcase Tumoroid-on-a-Chip Technology in Upcoming Webinar
Creative Biolabs is set to host a webinar on tumoroid-on-a-chip technology, highlighting its potential to revolutionize cancer research and drug development by offering more physiologically relevant conditions for preclinical testing.
Xtant Medical Collaborates with B2i Digital to Highlight Orthobiologics Innovation to Investors
Xtant Medical's partnership with B2i Digital aims to educate investors on its orthobiologics platform and market potential, showcasing its growth in the medical technology sector.
GeoVax Advances in Vaccine Development and Immunotherapy with Promising Clinical Data
GeoVax Labs reports significant progress in its vaccine and immunotherapy pipeline, including favorable regulatory guidance for GEO-MVA and robust immune responses from GEO-CM04S1 in CLL patients, highlighting the company's potential to address urgent medical needs.
Fifty 1 Labs to Host Virtual Shareholder Teleconference Featuring Nobel Laureate Dr. James Orbinski
Fifty 1 Labs announces a virtual shareholder teleconference to discuss its strategic roadmap, including AI-driven drug repurposing and significant R&D investments, highlighting its commitment to innovation in health and wellness.
Clene Inc. Advances Toward FDA Approval for ALS Treatment, Highlighting Market Potential
Clene Inc. is making significant progress toward FDA accelerated approval for its ALS drug CNM-Au8®, targeting a $1.3 billion market by 2034 with a novel approach to neurodegenerative diseases.
Fifty 1 Labs to Showcase AI-Driven Health Innovations in Virtual Shareholder Teleconference
Fifty 1 Labs, Inc. (OTC: FITY) announces a virtual shareholder teleconference featuring Nobel Laureate Dr. James Orbinski, highlighting the company's strategic advancements in AI-powered health and wellness solutions.
Lantern Pharma Strengthens Board with Appointment of Dr. Lee T. Schalop to Advance AI-Driven Oncology Research
Lantern Pharma enhances its AI-driven precision oncology efforts by appointing Dr. Lee T. Schalop, a seasoned biotech leader, to its Board of Directors.
Dr. Anna Chacón Featured on Negocios Magazine Cover for Pioneering Telemedicine in Dermatology
Dr. Anna Chacón's feature on Negocios Magazine highlights her innovative telemedicine model that revolutionizes access to dermatological care across the U.S., showcasing her blend of medical expertise and entrepreneurial vision.
Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Optimize Market Dynamics
Calidi Biotherapeutics Inc. (NYSE American: CLDI) will implement a 1-for-12 reverse stock split effective August 5, 2025, aiming to enhance market appeal and align with shareholder interests.
Fifty 1 Labs and UAV Corp to Host Virtual Shareholder Teleconference with Nobel Laureate Dr. James Orbinski
Fifty 1 Labs and UAV Corp announce a virtual shareholder teleconference featuring Nobel Laureate Dr. James Orbinski, highlighting strategic initiatives in AI-driven health solutions and biotech acquisitions.
HealthLynked Corp. Enhances Healthcare Solutions with New Website and Provider Directory Upgrades
HealthLynked Corp. launches an upgraded Enterprise Healthcare Solutions Website and enhances its provider directory, aiming to improve patient engagement and healthcare efficiency.
GeoVax Explores Needle-Free Vaccine Delivery with Vaxxas Technology
GeoVax Labs, Inc. initiates a research program to evaluate the potential of a needle-free, self-administered GEO-MVA vaccine using Vaxxas' HD-MAP technology, aiming to enhance global immunization efforts.
American Heart Association Expands Initiative to Combat Cardiovascular-Kidney-Metabolic Syndrome Across 15 U.S. Regions
The American Heart Association's expansion of its Cardiovascular-Kidney-Metabolic Health Initiative to 15 U.S. regions aims to address the interconnected conditions leading to heart disease and stroke, marking a significant step in public health intervention.
Lexaria's DehydraTECH-Semaglutide Shows Promising Reduction in Side Effects Compared to Rybelsus®
Lexaria Bioscience Corp. reports interim results from its Phase 1b study, showing DehydraTECH-semaglutide significantly reduces gastrointestinal and overall side effects compared to Rybelsus®, potentially improving patient adherence to treatment.
Phlow Corp. Secures $37 Million in Series C Funding to Enhance U.S. Pharmaceutical Supply Chain
Phlow Corp.'s recent $37 million Series C funding round, led by Align Private Capital, underscores its commitment to addressing critical shortages in essential medicines and advancing U.S.-based pharmaceutical manufacturing.
Law Offices of Mark T. Hurt Awards Scholarship to UF Sophomore for Holistic Health Vision
The Law Offices of Mark T. Hurt has awarded its 2025 scholarship to University of Florida sophomore Miniaris Montanez, recognizing her innovative approach to integrating arts into holistic physical therapy and her advocacy for underrepresented groups.
Holy Cross Health’s Wound Healing Program Honored for Excellence
Holy Cross Health's Wound Healing and Hyperbaric Program has been recognized with the Center of Distinction award by Healogics for its high patient satisfaction and wound healing rates, highlighting its commitment to advanced wound care.